retatrutide nonalcoholic fatty liver disease nash trial Retatrutide, the triple G, Glucagon-GIP-GLP-1 based triagonist produces substantial resolution of Fatty Liver Disease and Fibrosis

Eat fiber-rich carbohydrates (especially fermentable fiber) Choose healthy fats, especially olive oil, nuts, seeds, foods rich in omega-3s Prioritize protein in every meal Feed your gut microbiome with polyphenols, prebiotics, and probiotics Supporting the growth of bacteria like Akkermansia mucinilphila and Bifidobacterium both of which are linked to increased natural GLP-1 production may offer another layer of support

This is important for stabilizing blood sugars

That edges out tirzepatides 20.2% and semaglutides 13.7% from the head-to-head SURMOUNT-5 trial because each drug adds one more hormone receptor to the target list

This tailored approach allows patients to receive a treatment plan that addresses both the medical and behavioral aspects of weight management